137 related articles for article (PubMed ID: 18431232)
1. Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.
Shapiro R; Zeevi A; Basu A; Tan HP; Kayler LK; Blisard DM; Thai NL; Girnita AL; Randhawa PS; Gray EA; Marcos A; Starzl TE
Transplantation; 2008 Apr; 85(8):1125-32. PubMed ID: 18431232
[TBL] [Abstract][Full Text] [Related]
2. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.
Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Kayler LK; Erkan E; McFeaters CG; James G; Grosso MJ; Zeevi A; Gray EA; Marcos A; Starzl TE
Am J Transplant; 2007 Dec; 7(12):2736-8. PubMed ID: 17908272
[TBL] [Abstract][Full Text] [Related]
3. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.
Tan HP; Donaldson J; Basu A; Unruh M; Randhawa P; Sharma V; Morgan C; McCauley J; Wu C; Shah N; Zeevi A; Shapiro R
Am J Transplant; 2009 Feb; 9(2):355-66. PubMed ID: 19120078
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.
Willicombe M; Brookes P; Santos-Nunez E; Galliford J; Ballow A; Mclean A; Roufosse C; Cook HT; Dorling A; Warrens AN; Cairns T; Taube D
Am J Transplant; 2011 Mar; 11(3):470-7. PubMed ID: 21299828
[TBL] [Abstract][Full Text] [Related]
5. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience.
Tan HP; Donaldson J; Ellis D; Moritz ML; Basu A; Morgan C; Vats AN; Erkan E; Shapiro R
Transplantation; 2008 Dec; 86(12):1725-31. PubMed ID: 19104412
[TBL] [Abstract][Full Text] [Related]
6. Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.
Knechtle SJ; Pascual J; Bloom DD; Torrealba JR; Jankowska-Gan E; Burlingham WJ; Kwun J; Colvin RB; Seyfert-Margolis V; Bourcier K; Sollinger HW
Am J Transplant; 2009 May; 9(5):1087-98. PubMed ID: 19344431
[TBL] [Abstract][Full Text] [Related]
7. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
Marcos A; Eghtesad B; Fung JJ; Fontes P; Patel K; Devera M; Marsh W; Gayowski T; Demetris AJ; Gray EA; Flynn B; Zeevi A; Murase N; Starzl TE
Transplantation; 2004 Oct; 78(7):966-71. PubMed ID: 15480160
[TBL] [Abstract][Full Text] [Related]
8. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
Tan HP; Kaczorowski D; Basu A; McCauley J; Marcos A; Donaldson J; Unruh M; Randhawa P; Zeevi A; Shapiro R
Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087
[TBL] [Abstract][Full Text] [Related]
9. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
Tan HP; Kaczorowski DJ; Basu A; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
Transplantation; 2004 Dec; 78(11):1683-8. PubMed ID: 15591960
[TBL] [Abstract][Full Text] [Related]
10. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.
Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Khan AS; Gray EA; Zeevi A; McFeaters C; James G; Jo Grosso M; Marcos A; Starzl TE
J Pediatr; 2006 Jun; 148(6):813-8. PubMed ID: 16769394
[TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
12. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.
Tan HP; Kaczorowski DJ; Basu A; Unruh M; McCauley J; Wu C; Donaldson J; Dvorchik I; Kayler L; Marcos A; Randhawa P; Smetanka C; Starzl TE; Shapiro R
Am J Transplant; 2006 Oct; 6(10):2409-17. PubMed ID: 16889606
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
Villanueva ME; Muñoz AS; Casasola CC; Africa JB; Danguilan RA; Ona ET
Transplant Proc; 2008 Sep; 40(7):2222-5. PubMed ID: 18790198
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.
Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK
Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial.
Chan K; Taube D; Roufosse C; Cook T; Brookes P; Goodall D; Galliford J; Cairns T; Dorling A; Duncan N; Hakim N; Palmer A; Papalois V; Warrens AN; Willicombe M; McLean AG
Transplantation; 2011 Oct; 92(7):774-80. PubMed ID: 21836540
[TBL] [Abstract][Full Text] [Related]
18. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
19. Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.
Ellis D; Shapiro R; Moritz M; Vats A; Basu A; Tan H; Kayler L; Janosky J; Starzl TE
Transplantation; 2007 Jun; 83(12):1563-70. PubMed ID: 17589338
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
Ciancio G; Burke GW; Gaynor JJ; Carreno MR; Cirocco RE; Mathew JM; Mattiazzi A; Cordovilla T; Roth D; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J
Transplantation; 2005 Aug; 80(4):457-65. PubMed ID: 16123718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
